Central Nervous System Lymphoma
📧 Sign up to get email alerts when something new happens for Central Nervous System Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]
The Phase 2 trial of antineoplaston therapy for primary central nervous system lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-18Clinical Trial Update: Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL [EARLY_Phase 1]
A Phase 1 pilot trial evaluating motexafin gadolinium with high-dose methotrexate-based chemoimmunotherapy and radiation for newly diagnosed…
-
CLINICAL_TRIALS withdrawal · 2012-03-20Clinical Trial Update: Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]
A Phase 2 trial evaluating chemotherapy with filgrastim and radiation therapy for primary central nervous system lymphoma has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2011-09-20Clinical Trial Update: Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating pemetrexed for recurrent or progressive primary central nervous system lymphoma has been withdrawn. The …